Comparison of incident breast cancer cases in the largest national US tumor registries
Cancer · 2025
DOI: 10.1002/cncr.35525 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer, 2025. Verfasst von Jennifer K Plichta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Registries, SEER Program. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Background
This study compared incident breast cancer cases in the National Cancer Database (NCDB) and Surveillance, Epidemiology, End Results Program (SEER) to a national population cancer registry.
Methods
Patients with malignant or in situ breast cancer (BC) 2010–2019 in the NCDB and SEER were compared to the US Cancer Statistics (USCS). Case coverage was estimated as the number of patients in the NCDB/SEER as a proportion of USCS cases.
Results
The USCS reported 3,047,509 patients; 77.5% patients were included in the NCDB and 46.0% in SEER. Case ascertainment varied significantly by patient sex (both registries, p < .001). For males, 84.1% were captured in the NCDB, whereas only 77.5% of females were included. Case coverage in SEER was better for females than males (46.1% vs. 43.5%). Registries varied significantly by race/ethnicity (both p < .001). Case coverage in the NCDB was highest for non‐Hispanic White (78.2%), non‐Hispanic Black (77.7%), and non‐Hispanic Asian or Pacific Islander (72.5%) BC patients, and lowest for Hispanic (56.4%) and non‐Hispanic American Indian/Alaska Native (41.1%) patients. In SEER, case coverage was highest for non‐Hispanic Asian or Pacific Islander (78.1%) and Hispanic (69.6%) patients and it was significantly lower for all other subgroups (non‐Hispanic Black, 44.8%; non‐Hispanic White, 42.4%; and non‐Hispanic American Indian/Alaska Native, 36.6%).
Conclusions
National US tumor registries provide data for a large sampling of breast cancer patients, yet significant differences in case coverage were observed based on age, sex, and race/ethnicity. These findings suggest that analyses using these data sets and interpretation of findings should account for these meaningful variances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
- Department of Population Health Sciences, Duke University Medical Center, Durham, North Carolina, USA.
- Duke Cancer Institute, Durham, North Carolina, USA.
- Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
- American College of Surgeons Cancer Programs, Chicago, Illinois, USA.
- Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Jennifer K Plichta, Tori C Chanenchuk
Förderung
- NCATS NIH HHS
- NIH HHS
- NIAMS NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Plichta, J. K., Thomas, S. M., Chanenchuk, T. C., Chan, K., Hyslop, T., Hwang, E. S., & Greenup, R. A. (2025). Comparison of incident breast cancer cases in the largest national US tumor registries. Cancer. https://doi.org/10.1002/cncr.35525
Vancouver
Plichta JK, Thomas SM, Chanenchuk TC, Chan K, Hyslop T, Hwang ES, et al. Comparison of incident breast cancer cases in the largest national US tumor registries. Cancer. 2025. doi:10.1002/cncr.35525
BibTeX
@article{Plichta2025,
author = {Plichta, Jennifer K and Thomas, Samantha M and Chanenchuk, Tori C and Chan, Kelley and Hyslop, Terry and Hwang, E Shelley and Greenup, Rachel A},
title = {Comparison of incident breast cancer cases in the largest national US tumor registries},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35525}
}
EUVIMED